Comparison between a clinical activity index (Harvey-Bradshaw-Index), laboratory inflammation markers and quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound in Crohn's disease.

PURPOSE Due to its character as a remitting inflammatory disease, patients suffering from Crohn's disease (CD) often undergo several imaging studies subjecting the mostly young patients to ionizing. Contrast enhanced ultrasound for capillary microvascular assessment might be a new diagnostic tool for identifying the activity of inflammation by ultrasound techniques. MATERIALS AND METHODS We prospectively evaluated 45 patients with proven Crohn's disease performing contrast enhanced ultrasound (CEUS) and laboratory assessment including C-reactive protein (CRP), leucocytes and hematocrit as well as calculating the Harvey-Bradshaw Index (HBI). Thereafter, we applied the quantification software Qontrast(®) to obtain contrast-enhanced sonographic perfusion maps. RESULTS Analysis of the 41 finally included patients revealed a correlation of CRP to HBI and TTP[s], respectively. Moreover, an association was found for HBI and TTP[s] and for HBI and TTP[s]/Peak [%]. Analysis of 34 patients with a Peak [%] ≥ 25 showed a close association of HBI and CRP. Besides, in these patients CRP correlated to TTP[s] and to TTP[s]/Peak [%]. We found a strong negative correlation between HBI and TTP[s] (r = -0.645, p<0.01), thus, the higher the clinical activity the shorter the time-to-peak. CONCLUSION Quantitative evaluation with CEUS, particularly the calculation of TTP[s] in patients with a Peak [%] ≥ 25, provides a simple method to assess the inflammatory activity in CD.

[1]  A. Michalsen,et al.  Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices , 2008, The American Journal of Gastroenterology.

[2]  E. Quaia,et al.  Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease. , 2009, Gastroenterology.

[3]  E. Jung,et al.  Quantitative assessment of bowel wall vascularisation in Crohn's disease with contrast-enhanced ultrasound and perfusion analysis. , 2009, Clinical hemorheology and microcirculation.

[4]  K. Nuessle,et al.  Diagnostic imaging in Crohn’s disease: comparison of magnetic resonance imaging and conventional imaging methods , 2000, International Journal of Colorectal Disease.

[5]  L. Guidi,et al.  Contrast-enhanced ultrasonography with SonoVue after infliximab therapy in Crohn's disease. , 2006, European review for medical and pharmacological sciences.

[6]  F. Brahme,et al.  A comparative radiographic and pathological study of intestinal vaso-architecture in Crohn's disease and in ulcerative colitis , 1970, Gut.

[7]  R. Pounder,et al.  PATHOGENESIS OF CROHN'S DISEASE: MULTIFOCAL GASTROINTESTINAL INFARCTION , 1989, The Lancet.

[8]  B. Wiedenmann,et al.  Clinical Relevance of Transabdominal Ultrasonography and Magnetic Resonance Imaging in Patients With Inflammatory Bowel Disease of the Terminal Ileum and Large Bowel , 2004, Inflammatory bowel diseases.

[9]  S. Raptis,et al.  Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case‐series study using wireless capsule endoscopy , 2008, Inflammatory bowel diseases.

[10]  P. Rutgeerts,et al.  Laboratory markers in IBD: useful, magic, or unnecessary toys? , 2006, Gut.

[11]  M. Regueiro,et al.  Crohn's disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection , 2011, Inflammatory bowel diseases.

[12]  W. Kratzer,et al.  Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn’s disease , 2009, European Radiology.

[13]  P. Rutgeerts,et al.  A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. , 2002, Gastroenterology.

[14]  D. Koh,et al.  Ultrasound and magnetic resonance imaging assessmentof active bowel segments in Crohn's disease. , 2002, Clinical radiology.

[15]  W. Best Predicting the Crohn's disease activity index from the harvey‐bradshaw index , 2006, Inflammatory bowel diseases.

[16]  E. Quaia,et al.  Inflammatory activity in Crohn disease: ultrasound findings , 2008, Abdominal Imaging.

[17]  E. Jung,et al.  Comparison between Preoperative Quantitative Assessment of Bowel Wall Vascularization by Contrast-Enhanced Ultrasound and Operative Macroscopic Findings and Results of Histopathological Scoring in Crohn’s Disease , 2010, Ultraschall in der Medizin.

[18]  M. Cova,et al.  The diagnostic value of small bowel wall vascularity after sulfur hexafluoride-filled microbubble injection in patients with Crohn's disease. Correlation with the therapeutic effectiveness of specific anti-inflammatory treatment. , 2009, European journal of radiology.

[19]  Weskott Hp Emerging roles for contrast-enhanced ultrasound. , 2008 .

[20]  R. F. Harvey,et al.  A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY , 1980, The Lancet.